Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells

Leukemia
Isabel MarzoJavier Naval

Abstract

B-cell chronic lymphocytic leukemia (B-CLL) cells develop resistance to nucleoside analogs over time. This chemoresistance may be caused by selection for B-CLL cells with defects in the particular apoptosis pathway triggered by these drugs. Therefore, anticancer agents that induce apoptosis through alternative pathways might be useful in treating chemoresistant B-CLL. Farnesyltransferase inhibitors (FTIs) are a class of synthetic drugs with definite molecular targets, which have demonstrated cytotoxicity against leukemic cell lines. We have studied the ex vivo effect of the FTI BMS-214662 on cells from 18 patients with B-CLL. Low concentrations (<1 microM) of BMS-214662 prevented farnesylation of the chaperone marker HDJ-2 and had no effect on Akt activation. BMS-214662 induced apoptosis in B-CLL cells from all patients studied, including those showing resistance to cladribine and fludarabine ex vivo and in vivo. Treatment with BMS-214662 induced loss of mitochondrial membrane potential (DeltaPsi(m)), phosphatidylserine exposure, proapoptotic conformational changes of Bax and Bak, reduction in Mcl-1 levels and activation of caspases 9 and 3. The general caspase inhibitor Z-VAD-fmk did not prevent BMS-214662-induced cell death. ...Continue Reading

References

Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A NeriR Dalla-Favera
Dec 6, 1996·The Journal of Biological Chemistry·D M VanagsS Orrenius
Jul 20, 1999·The Journal of Biological Chemistry·D G KirschJ M Hardwick
Jul 6, 2000·Current Opinion in Hematology·T J Kipps
Jul 10, 2001·Acta Oncologica·E KimbyUNKNOWN SBU-group. Swedish Council of Technology Assessment in Health Care
Nov 28, 2001·Hematology·K R RaiE Montserrat
Aug 24, 2002·The Journal of Biological Chemistry·Theocharis PanaretakisDan Grandér
Jun 5, 2003·Expert Opinion on Investigational Drugs·Francesco CaponigroJane Bryce
Aug 28, 2003·Archives of Biochemistry and Biophysics·Daniel Iglesias-SerretJosé M López
Jan 23, 2004·Nature Reviews. Cancer·Saïd M Sebti, Channing J Der
Apr 8, 2004·Molecular Cell·Xiao-Ming SunGerald M Cohen

❮ Previous
Next ❯

Citations

Jul 22, 2005·Cancer Immunology, Immunotherapy : CII·Øystein BruserudBjørn Tore Gjertsen
Jun 3, 2009·Nature Reviews. Clinical Oncology·Lisa PleyerRichard Greil
Jul 13, 2006·Cancer·Tomislav LetilovicAlessandra Ferrajoli
Aug 23, 2005·Cancer Chemotherapy and Biological Response Modifiers·Peter H Wiernik
Nov 10, 2005·Journal of Lipid Research·Andrea D BassoW Robert Bishop

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.